Delayed-action clonidine capsules in the therapy of arterial hypertension

Turchetti, G.; Di Veroli, C.

La Clinica Terapeutica 97(6): 605-611

1981


ISSN/ISBN: 0009-9074
PMID: 7273662
Document Number: 175341
A clonidine dosage-form, perlongetten which releases the active principle gradually during 6 h after ingestion was submitted to clinical trial. Of 30 patients, 17 (with mild hypertension) responded to a single daily capsule; the remaining patients required 2 capsules daily or 2 capsules plus a diuretic. Perlongetten was effective and improved patient compliance. Side effects were reduced.

Document emailed within 1 workday
Secure & encrypted payments